ArticleFrontiers in immunology2024

Case report: Efgartigimod is a novel therapeutic option for ocular myasthenia gravis: a report of 2 cases.

Tianying Ma et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.